查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1741239

美容医疗市场：按程序和地区划分

Aesthetic Medicine Market, By Procedure and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025年，美容医疗市场规模估计为2,220.3亿美元，预计到2032年将达到5,728.6亿美元，2025年至2032年的年复合成长率（CAGR）为14.5%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 2220.3亿美元
效能数据 2020-2024 预测期 2025-2032
预测期：2025-2032年复合年增长率： 14.50% 2032年价值预测 5728.6亿美元

美容医学是现代医学的一个分支，专注于透过治疗皱纹、皮肤鬆弛、皮肤变色、痣、疤痕、黄褐斑、脂肪团、多余脂肪、蜘蛛蜘蛛网状静脉曲张、多余毛髮等来改变美容外观。因此，随着人们越来越注重自己的整体外观，全球对美容医学的需求也迅速成长。

市场动态：

老年人口的增加、微创治疗的采用率的提高、对美容治疗的需求增加以及人们对整体外观和美容手术的认识不断提高是预计在预测期内推动全球美容医学市场增长的关键因素。

例如，2023年6月，BoomerangFX宣布与医疗技术先驱DrFirst合作，为客户提供一个整合的药物管理平台，最大限度地提高临床工作流程和病人参与。 BoomerangFX已与DrFirst合作，为北美的美容医疗诊所推出电子处方。

然而，整容手术成本高、社会耻辱和报销不足等因素预计将阻碍全球美容医疗市场的成长。

本研究的主要特点

  • 本报告对全球美容医疗市场进行了详细分析，并以 2024 年为基准年，展示了 2025 年至 2032 年预测期内的市场规模和年复合成长率（CAGR%）。
  • 它揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 该报告涵盖了全球美容医疗市场的主要企业概况，基于以下参数，例如公司亮点、产品系列、主要亮点、财务表现和策略。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球美容医学市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 可以透过用于分析全球美容医学市场的各种策略矩阵来促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 美容保养需求旺盛
    • 美容疗程费用高昂
    • 意识提升
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章 全球美容医疗市场-冠状病毒（COVID-19）大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

第五章。 2020 年至 2032 年按程序分類的全球美容医疗市场

  • 侵入性操作
  • 隆乳手术
  • 抽脂手术
  • 鼻部手术
  • 眼睑手术
  • 腹部手术
  • 其他的
  • 非侵入性治疗
  • 肉毒桿菌注射
  • 软组织填充剂
  • 化学换肤
  • 雷射除毛
  • 微晶换肤
  • 其他的

第六章 全球美容医疗市场（按地区划分），2020-2032 年

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第七章 竞争态势

  • Alma Laser
  • Hologic, Inc.（Cynosure）
  • Abbvie（Allergan）
  • Solta Medical
  • Candela Medical
  • Merz Pharma GMBH
  • Revance Therapeutics Inc.
  • Lumenis
  • Galderma Pharmaceuticals SA
  • Johnson & Johnson Services, Inc.

第 8 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5983

Aesthetic Medicine Market is estimated to be valued at USD 222.03 Bn in 2025 and is expected to reach USD 572.86 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 222.03 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 14.50% 2032 Value Projection: USD 572.86 Bn

Aesthetic medicine is a branch of modern medicine that focuses on altering cosmetic appearance through the treatment of conditions such as wrinkles, skin laxity, skin discoloration, moles, scars, liver spots, cellulite, excess fat, spider veins, and/or unwanted hair, among others. Thus, with the increasing awareness among people about overall appearance, the demand for aesthetic medicine is also increasing with a rapid pace, worldwide.

Market Dynamics:

Growing geriatric population, increasing adoption of minimally invasive treatments, high demand for aesthetic treatments, and rising awareness among people about overall appearance or aesthetic procedures are major factors expected to boost the growth of the global aesthetic medicine market during the forecast period.

For instance, in June 2023, BoomerangFX announced that it has partnered with health technology pioneer DrFirst to offer clients the unified medication management platform to maximize clinical workflows and patient engagement. BoomerangFX partnered with DrFirst to launch e-prescribing for aesthetic medicine practices across North America.

However, factors such as high cost of aesthetic procedures, social stigma, and poor reimbursement are expected to hamper the growth of the global aesthetic medicine market.

Key features of the study:

  • This report provides in-depth analysis of the global aesthetic medicine market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global aesthetic medicine market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Hologic, Inc. (Cynosure), Abbvie (Allergan), Solta Medical, Candela Medical, Merz Pharma GMBH, Revance Therapeutics Inc., Lumenis, Alma Laser, Galderma Pharmaceuticals S.A., and Johnson & Johnson Services, Inc., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global aesthetic medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aesthetic medicine market.

Detailed Segmentation:

  • Global Aesthetic Medicine Market , By Procedure:
    • Invasive Procedures
    • Breast Augmentation
    • Liposuction
    • Nose Reshaping
    • Eyelid Surgery
    • Tummy Tuck
    • Others
    • Non-invasive Procedures
    • Botox Injections
    • Soft Tissue Fillers
    • Chemical Peel
    • Laser Hair Removal
    • Microdermabrasion
    • Others
  • Global Aesthetic Medicine Market By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • Alma Laser
    • Hologic, Inc. (Cynosure)
    • Abbvie (Allergan)
    • Solta Medical
    • Candela Medical
    • Merz Pharma GMBH
    • Revance Therapeutics Inc.
    • Lumenis
    • Galderma Pharmaceuticals S.A.
    • Johnson & Johnson Services, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Procedure
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • High demand for aesthetic treatments
    • High cost of aesthetic procedure
    • Increasing awareness among people
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Aesthetic Medicine Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Aesthetic Medicine Market, By Procedure, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Invasive Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Breast Augmentation
  • Liposuction
  • Nose Reshaping
  • Eyelid Surgery
  • Tummy Tuck
  • Others
  • Non-Invasive Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Botox Injections
  • Soft Tissue Fillers
  • Chemical Peel
  • Laser Hair Removal
  • Microdermabrasion
  • Others

6. Global Aesthetic Medicine Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)

7. Competitive Landscape

  • Alma Laser
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic, Inc. (Cynosure)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbvie (Allergan)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Solta Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Candela Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merz Pharma GMBH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Revance Therapeutics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lumenis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Galderma Pharmaceuticals S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

8. Section

  • Research Methodology
  • About us